Skip to main content

Peer Review reports

From: The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment

Original Submission
1 Sep 2016 Submitted Original manuscript
7 Oct 2016 Author responded Author comments - Christina Demuth
Resubmission - Version 2
7 Oct 2016 Submitted Manuscript version 2
1 Dec 2017 Author responded Author comments - Christina Demuth
1 Feb 2017 Reviewed Reviewer Report - Medhi Wangpaichitr
2 Oct 2017 Reviewed Reviewer Report - Kenichi Suda
Resubmission - Version 3
1 Dec 2017 Submitted Manuscript version 3
7 Dec 2017 Author responded Author comments - Christina Demuth
1 Dec 2017 Reviewed Reviewer Report - Kenichi Suda
Resubmission - Version 4
7 Dec 2017 Submitted Manuscript version 4
18 Dec 2017 Reviewed Reviewer Report - Kenichi Suda
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
8 Feb 2018 Editorially accepted
15 Feb 2018 Article published 10.1186/s12885-018-4108-0

You can find further information about peer review here.

Back to article page